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affairs, serving as Chairman of the Southern Transvaal Branch 
and as a member of the Federal Council. He was also involved 
in the modernisation of ambulance services and spent many 
hours lecturing to aspirant paramedics. Another interest was 
the Johannesburg Clinical and Pathological Club, started by his 
father and later called the John Saner Club. In due course, Bob 
became its chairman. 
While this brief résumé gives some idea of the range of Bob 
Saner’s interests, it does little to define the special nature of 
his contribution. In an environment increasingly dominated 
by technology and material considerations, Bob practised old-
fashioned medicine, totally in tune with the proud traditions 
of the past. His compassion and commitment, coupled with 
considerable clinical abilities and absolute professionalism, 
endeared him to his patients and earned the deep respect and 
affection of his colleagues and friends. 
Bob’s family life was a happy one. He was an avid sea and 
trout fisherman and loved nothing more than a good red wine 
and an after-dinner tawny port in the company of friends. 
He also spent many rewarding hours as an oil painter and 
exhibited his pictures on several occasions. He is survived by 
his beloved wife, Jane, and three children.
TH Bothwell
Treating asthma
Asthma is an increasingly common disease and one that most 
GPs and specialist physicians will have plenty of experience 
of. But, as an asthmatic myself, I know that often, both the 
doctor’s expectation of what constitutes good asthma treatment 
and the patient’s expectations of what life is like with asthma, 
fall far short of what can actually be achieved. For most 
asthmatics, a completely normal life should be possible, with 
the correct medication. Recent studies of patients’ priorities 
for asthma care showed a recurrent theme – the importance 
of the doctor-patient relationship. According to an article in a 
recent edition of the Medical Journal of Australia, improving the 
implementation of the asthma guidelines requires not only 
insights into the perspectives of those living with asthma, but 
also an understanding of what GPs priorities are for achieving 
optimal outcomes in people with asthma and the barriers they 
feel they face in delivering this care.
Diane Goeman and her colleagues set out to answer the 
question, ‘What do you think is needed to achieve best 
outcomes in people with asthma?’ They used something called 
the nominal group technique, a highly structured meeting that 
is used to gain information from experts about a particular 
issue. The study was carried out between August 2002 and 
September 2003. Forty-nine GPs, 34 from urban areas and 15 
from rural areas, split into 6 groups, were asked to participate. 
All the groups nominated asthma education for patients and 
continuing professional education for GPs as major priorities. 
They also described problems with meeting these priorities. 
Other priorities were adherence to medication, facilitating 
regular patient review, negotiated treatment/management 
plans, making the correct diagnosis, being paid more for 
asthma care and having more consultation time and safer 
asthma medications and access to these. Health promotion 
initiatives and increased public awareness were also cited 
as priorities. Most GPs admitted being uncomfortable using 
spirometry and written asthma action plans were not a high 
priority.
This study identified gaps between current asthma 
guidelines and Australian GPs' priorities for optimal asthma 
care. The top priorities identified by GPs are not given the 
same prominence in local asthma guidelines. The authors 
suggest that, to deliver asthma care according to GPs' priorities, 
broader issues such as facilitating relationships with patients, 
making an accurate diagnosis, establishing a patient recall 
system and finding the time to provide asthma education, need 
to be addressed. Although there was broad support for asthma 
management plans, GPs did not see written asthma action 
plans to deal with severe exacerbations as a priority. This is 
consistent with studies from Britain that show a decline in the 
use of these management plans in the UK. 
Spirometry is recommended to improve diagnosis and also 
to help patients to comply with treatment. However, many 
GPs thought that spirometers were too expensive to have in 
their practices and were also underconfident in using them, 
particularly those from rural areas, where spirometers might be 
even more useful because of lack of easy access to specialists. 
The bottom line appeared to be that GPs were delivering 
asthma care in the way that they found easiest and not 
necessarily according to the asthma treatment guidelines. 
This may be fine, if most GPs are managing to control 
their asthmatic patients so that the patients seldom have 
exacerbations. However, my experience of treating asthma 
in primary care, both here in the state system and in Britain, 
is that asthma patients are generally treated suboptimally 
and suffer unnecessary exacerbations. Asthma is, to me, a 
poorly understood disease. Some years ago I heard a specialist 
respiratory physician speak almost disparagingly of the long-
acting bronchodilators that I have been using for the past 
decade and which have transformed my life as an asthmatic. 
Hopefully, increasing experience of their use has changed 
his mind. But herein lies the problem. Asthma treatment 
has improved beyond all recognition in the past decade. All 
but the most brittle asthmatics should now be able to live a 
completely normal life, with no exacerbations at all if they 
are on the correct medication and with completely normal 
effort tolerance. My experience is that few doctors, let alone 
the asthmatics themselves, expect this as the main outcome of 
treatment. Symptoms are expected and regarded as normal. 
I would have been very interested to have taken part in the 
group discussions to see exactly where it was that the GPs felt 
they and their patients lacked information and understanding. 
Goeman DP, et al. MJA 2005; 183: 457.
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An elderly acquaintance of mine has found it increasingly 
difficult to sleep through the night over the years. I am sure 
that there is a treatable component to his insomnia, such as 
depression, but, not being his doctor, I have not had the chance 
to do anything about this. What has happened, however, 
is that he has become increasingly dependent on sedative 
hypnotics, although these drugs are becoming less effective as 
he continues to use them. This pattern of poor sleep and drug 
use is, I’m sure, familiar to many of you reading this. Some of 
you may have prescribed sedative hypnotics to your elderly 
patients and have no doubt found them to be of variable 
efficacy. We know that their use is common. Between 5% and 
33% of elderly people in the USA and Britain are prescribed 
a benzodiazepine or a benzodiazepine receptor agonist for 
sleep problems. However, there is also evidence of adverse 
effects associated with sedative use such as ataxia, falls, and 
memory loss and these have the potential for being particularly 
problematic for older people. A recent paper in the British 
Medical Journal reports that, although there is widespread use of 
sedative hypnotics in older people, we have no idea whether 
they are actually doing any good and whether they may, in 
fact, be doing harm.
Jennifer Glass and her colleagues set out to quantify and 
compare the potential benefits, in the form of subjective reports 
of sleep benefits and risks, of adverse events and morning-
after psychomotor impairment, of short-term treatment with 
sedative hypnotics in older people with insomnia. Using 
Medline, Embase, the Cochrane clinical trials database, 
PubMed and PsychLit from 1966 to 2003, they examined 
randomised controlled trials of any pharmacological treatment 
for insomnia for at least 5 consecutive nights in people aged 
60 or over who had insominia, but no other psychiatric or 
psychosocial disorder.
They looked at 24 studies that involved 2 417 people. These 
studies showed that sleep quality improved, total sleep time 
increased and the number of night time awakenings decreased 
in those who were using sedatives compared with those who 
were using placebo. However, the studies also showed that 
adverse effects were more common in those using sedatives 
compared with those using placebo. Adverse cognitive effects 
were 4.78 times more common, adverse psychomotor effects 
were 2.61 times more common and reports of daytime tiredness 
were 3.82 times more common in people using a sedative 
hypnotic compared with those using placebo.
The authors concluded that, while improvements in sleep 
in those using sedative hypnotics were statistically significant, 
the magnitude of the effect is small. Furthermore, the increased 
risk of adverse events is statistically significant and potentially 
clinically relevant in older people, who may be at risk of falls 
and cognitive impairment. So, in people over the age of 60 
the benefits of these drugs may not justify the increased risks 
associated with their use. It is worth pointing out that the 
studies that were examined looked at relatively short-term use 
of benzodiazepines. We are all familiar with the patient who 
has been using ‘sleeping pills’ for many years. There is an all 
too easy acceptance of cognitive decline, unsteadiness and 
daytime tiredness as simply being part of ‘old age’. Perhaps 
we should look more closely at a person’s medication before 
making subjective judgements about what causes this apparent 
steady decline.




Edited by Dhavendra Kumar. Pp. xv + 579, Illustrated.  £145. 
Kluwer Academic Publishers. 2004. ISBN 1-4020-1215-2.
In this excellent monograph, Dhavendra Kumar and forty 
expert contributors have provided a comprehensive overview 
of genetic conditions that have been identified in persons with 
origins of the Indian subcontinent.
The first section of this 607-page book contains accounts of 
the historical, social and demographic factors that underlie the 
rich ethnic and cultural diversity of the population of India.  
In the second section, specific genetic conditions or categories 
of heritable disorders which are of special importance 
are reviewed. The third and last section is devoted to the 
implications and management of  genetic disorders in India 
and Sri Lanka.
The wide range of academic interests of the contributors 
is reflected in the content of the individual chapters.  The 
overall standard is high, although inevitably, there is a certain 
amount of overlap and repetition.  The quality of the printing 
and presentation of this hardback book is good, while the 
illustrations and tables are informative.  The references are 
extensive and relevant and the idea is well formulated.
Immigrant communities in many parts of the world have 
ancestral links with the Indian subcontinent, and their current 
genetic endowment reflects these origins.  For this reason, this 
magisterial book is relevant at an international level.  The time 
is ripe for similar works focused on specific immigrant Indian 
communities; Southern Africa has a pressing need in this 
respect.
Peter Beighton
Emeritus Professor of Human Genetics
University of Cape Town
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